Isabel Peligros Selected Research

Proteins (Proteins, Gene)

10/2013

Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabel Peligros Research Topics

Disease

3	Rectal Neoplasms (Rectal Cancer) 01/2020 - 10/2013
3	Neoplasms (Cancer) 01/2020 - 03/2010
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2023
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Colitis 01/2022
1	Dysbiosis 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Liver Failure 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 03/2010

Drug/Important Bio-Agent (IBA)

1	MucinsIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2013
1	Epidermal Growth Factor (EGF)IBA 10/2013
1	Proteins (Proteins, Gene)FDA Link 10/2013

Therapy/Procedure

3	Liver Transplantation 01/2023 - 03/2010
1	Drug Therapy (Chemotherapy) 01/2018
1	Hepatectomy 01/2017
1	Radiotherapy 07/2014
1	Induction Chemotherapy 10/2013
1	Neoadjuvant Therapy 10/2013